Hepatocellular carcinoma despite long‐term survival in chronic tyrosinaemia I
- 1 December 2000
- journal article
- case report
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 23 (8) , 791-804
- https://doi.org/10.1023/a:1026756501669
Abstract
Tyrosinaemia I (fumarylacetoacetate hydrolase deficiency) is an autosomal recessive inborn error of tyrosine metabolism that produces liver failure in infancy or a more chronic course of liver diseas...Keywords
This publication has 29 references indexed in Scilit:
- The Mutagenicity of the Tyrosine Metabolite, Fumarylacetoacetate, Is Enhanced by Glutathione DepletionBiochemical and Biophysical Research Communications, 1997
- Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type INature Genetics, 1996
- Hereditary Tyrosinemia Type I: A New Clinical Classification With Difference in Prognosis on Dietary TreatmentHepatology, 1994
- Self-induced correction of the genetic defect in tyrosinemia type I.Journal of Clinical Investigation, 1994
- Hereditary tyrosinemia type I. Self-induced correction of the fumarylacetoacetase defect.Journal of Clinical Investigation, 1993
- Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenaseThe Lancet, 1992
- Renal failure in adult patients with hereditary tyrosinaemia type IJournal of Inherited Metabolic Disease, 1990
- Liver transplantation in a 23-year-old tyrosinaemia patient: Effects on the renal tubular dysfunctionJournal of Inherited Metabolic Disease, 1986
- The occurrence of hepatoma in the chronic form of hereditary tyrosinemiaThe Journal of Pediatrics, 1976
- Tyrosinemia: An inborn error of tyrosine metabolism with cirrhosis of the liver and multiple renal tubular defects (de Toni-Debré-Fanconi syndrome)The Journal of Pediatrics, 1965